BlackRock, Inc. 13D and 13G filings for REGENXBIO Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-08 6:45 pm Sale | 2024-12-31 | 13G | REGENXBIO Inc. RGNX | BlackRock Inc. BLK | 5,466,102 11.000% | -2,741,446 (-33.40%) | Filing |
| 2024-01-19 2:40 pm Purchase | 2023-12-31 | 13G | REGENXBIO Inc. RGNX | BlackRock Inc. BLK | 8,207,548 18.700% | 1,521,198 (+22.75%) | Filing |
| 2023-01-23 3:52 pm Purchase | 2022-12-31 | 13G | REGENXBIO Inc. RGNX | BlackRock Inc. BLK | 6,686,350 15.400% | 114,912 (+1.75%) | Filing |
| 2022-01-27 5:14 pm Unchanged | 2021-12-31 | 13G | REGENXBIO Inc. RGNX | BlackRock Inc. BLK | 6,571,438 15.400% | 0 (Unchanged) | Filing |
| 2022-01-26 09:16 am Purchase | 2021-12-31 | 13G | REGENXBIO Inc. RGNX | BlackRock Inc. BLK | 6,571,438 15.400% | 1,138,066 (+20.95%) | Filing |
| 2021-01-26 2:22 pm Purchase | 2020-12-31 | 13G | REGENXBIO Inc. RGNX | BlackRock Inc. BLK | 5,433,372 14.500% | 204,492 (+3.91%) | Filing |